Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TP53 polymorphism in plasma cell myeloma.
Zmorzynski SA, Korszen-Pilecka I, Wojcierowska-Litwin M, Kwiatkowska-Drabik B, Luterek M, Chocholska S, Koczkodaj D, Popek S, Michalak-Wojnowska M, Swiderska-Kolacz G, Januszewska J, Surowiec I, Tomczak W, Hus M, Dmoszynska A, Pasiarski M, Poniewierska-Jasak K, Cieplinska K, Jankowska-Lecka O, Filip AA. Zmorzynski SA, et al. Among authors: pasiarski m. Folia Histochem Cytobiol. 2017;55(4):203-211. doi: 10.5603/FHC.a2017.0022. Epub 2018 Jan 15. Folia Histochem Cytobiol. 2017. PMID: 29333597
Real‑life experience with bortezomib‑based regimens in elderly patients with newly diagnosed multiple myeloma and comorbidities: a Polish retrospective multicenter study.
Hus I, Walter-Croneck A, Masternak A, Jurczyszyn A, Usnarska-Zubkiewicz L, Bołkun Ł, Druzd-Sitek A, Rymko M, Łętowska J, Lech-Marańda E, Pasiarski M, Dmoszyńska A. Hus I, et al. Among authors: pasiarski m. Pol Arch Intern Med. 2017 Nov 30;127(11):765-774. doi: 10.20452/pamw.4099. Epub 2017 Sep 14. Pol Arch Intern Med. 2017. PMID: 28906482 Free article.
Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium.
Iskierka-Jażdżewska E, Canzian F, Stępień A, Martino A, Campa D, Stein A, Krawczyk-Kuliś M, Rybicka-Ramos M, Kyrcz-Krzemień S, Butrym A, Mazur G, Jurczyszyn A, Zawirska D, Grząśko N, Tomczak W, Subocz E, Wątek M, Pasiarski M, Rymko M, Całbecka M, Druzd-Sitek A, Walewski J, Kruszewski M, Raźny M, Zaucha JM, Dudziński M, Gaj P, Robak T, Warzocha K, Jamroziak K. Iskierka-Jażdżewska E, et al. Among authors: pasiarski m. Leuk Lymphoma. 2020 Mar;61(3):699-706. doi: 10.1080/10428194.2019.1689391. Epub 2019 Nov 20. Leuk Lymphoma. 2020. PMID: 31746254
Immunological Prognostic Factors in Multiple Myeloma.
Bębnowska D, Hrynkiewicz R, Grywalska E, Pasiarski M, Sosnowska-Pasiarska B, Smarz-Widelska I, Góźdź S, Roliński J, Niedźwiedzka-Rystwej P. Bębnowska D, et al. Among authors: pasiarski m. Int J Mol Sci. 2021 Mar 30;22(7):3587. doi: 10.3390/ijms22073587. Int J Mol Sci. 2021. PMID: 33808304 Free PMC article. Review.
Intermediate-dose Ara-C plus G-CSF for stem cell mobilization in patients with lymphoid malignancies, including predicted poor mobilizers.
Giebel S, Kruzel T, Czerw T, Sadus-Wojciechowska M, Najda J, Chmielowska E, Grosicki S, Jurczyszyn A, Pasiarski M, Nowara E, Glowala-Kosinka M, Chwieduk A, Mitrus I, Smagur A, Holowiecki J. Giebel S, et al. Among authors: pasiarski m. Bone Marrow Transplant. 2013 Jul;48(7):915-21. doi: 10.1038/bmt.2012.269. Epub 2013 Jan 7. Bone Marrow Transplant. 2013. PMID: 23292239 Clinical Trial.
31 results